Technologies for health

Cluster of Excellence TRAIL

(Translational Research and Advanced Imaging Laboratory)

University Hospital Institute (IHU) Liryc

Facility of Excellence MUSIC

Trail© TRAIL


Objective: developing a cardiac exploration instrument to improve the defining of electrophysiological disorders of the heart.

Under the leadership of Pierre Jaïs.



Pierre Jaïs
Director of MUSIC


 120 cases of atrial fibrillation and 20 cases of atrial tachycardia treated every year through MUSIC
Over 150 patients were treated on site with the MUSIC software  
Over 40 patients were treated abroad within the consortium (see focus)  10 or so training sessions per year for doctors 
Pierre Jais, professeur de cardiologie à l'université de Bordeaux et cardiologue au CHU de Bordeaux

Thanks to MUSIC – the software we developed using a combination of X-ray and IRM equipment – we have wonderful guidance during the operation. It is possible to reconstruct in 3D the internal and external walls of the ventricular cavity. We thus see the thickness of the tissue, the coronary arteries, the phrenic nerves and all scarred areas. It’s as if we’ve turned on the light in a room in which we previously worked in the dark.

Pierre Jais,
professor of Cardiology at the University of Bordeaux and cardiologist at the CHU (University Hospital) of Bordeaux

Zoom ...
Consortium autour de MUSICConsortium autour de MUSIC

MUSIC a été couronné de succès et a entraîné la création d'un consortium de 18 centres dans le monde (consortium MUSIC) qui utilisent le logiciel MUSIC pour guider les ablations. Les présentations lors des réunions scientifiques (HRS, EUROPACE, CARDIOSTIM, VT VF Symposium, TV symposium...) ont généré beaucoup d'enthousiasme. Un serveur a été mis en place, permettant aux  partenaires de télécharger les images brutes de CT et/ou MR, et qui sont traitées en moins de 24h. Les modèles multiparamétriques sont envoyés pour être chargés dans leur système de navigation de cathéter. 18 centres aux États-Unis, en Europe et en Australie utilisent ce service régulièrement. Ce sont des centres leaders, mais aussi des centres non académiques à faible volume et, d'une manière intéressante, il semble que ce soit dans ces...


Objective: developing translational research in medical imaging, focusing on five fields of application: oncology, neurology, cardiology, pneumology and nephrology.

Under the leadership of Vincent Dousset.

Translational Research and Advanced Imaging Laboratory

TRAIL program seeks to facilitate interdisciplinary, collaborative basic and clinical research in image based diagnostics and novel bio-compatible technologies for evaluating treatments, interventions and drug delivery strategies. It will also provide valuation on imaging techniques for patient care, public health impact and medico-economics impact.

In 2007, a Bio-Imaging Institute called IBIO was inaugurated that brings together multi-disciplinary human resources and task forces (CNRS – CEA - INSERM – University of Bordeaux – CHU University Hospital – Cancer Institute) around the development of sciences for clinical imaging applications. TRAIL represents an opportunity for IBIO to move forward and create a strong organization for translational research in vivo imaging.
Innovate for better medical diagnosis and therapy.

Choosing the shortest way from bench to bedside, clinical practice and health decision making.

The TRAIL project will focus on seven WorkPackages according to recognized excellence expertise of partners and two emerging and original risk-taking topics. The development of each WP fosters the development of translational research with imaging specialties.

These WP will be applied to five Medecine-Applied fields of excellence:

  • Oncology
  • Neurology
  • Cardiology
  • Pneumology
  • Nephrology



Jean-François Bauger
General Manager


240 collaborators (physicists, biologists, mathematicians, chemists, computer scientists, clinicians...) 
47 publications  €8.360M in co-financing / €4M invested by TRAIL
18 industrial partners 8 patents  
Vincent Dousset, Directeur du LabEx Trail© François Guenet

TRAIL has strongly impacted the Bordeaux imaging community, by structuring research through 7 scientific pillars (work-packages) and by organizing multidisciplinarity between 8 core laboratories. The input of the 28 TRAIL granted projects made the cement to build translational research using the world-class imaging platform (part of national France Life Imaging infrastructure) and offered the capability to research from the most basic to clinical applications and cohort imaging in association with hospitals and cancer institutes. The leverage effect made it possible to raise 8,3M€ (1M€ private cofinancing) leading to 30 staff recruitments, 20 international collaborations, 4 European projects, 5 invited professors, 18 industrial partners, and a strong interaction with the “Initiative of Excellence” IdEx of Bordeaux and other PIA projects (Clusters on mathematics and on neurosciences, IHU Cardiology, i-Share, Ofsep).

Vincent Dousset,
Head of Trail 

Zoom ...
Brevet déposé : l'IRM 3D appliquée à l'imagerie du poumon

Le projet consiste à développer une méthode d’analyse quantitative du remodelage bronchique sur des volumes pulmonaires acquis en IRM 3D. 

Translational Research© TRAILTranslational Research

Translational research involves developing techniques and applying them to humans. A good example of TRAIL: Focused UltraSound (FUS). After technology maturation and multiple trials, a prototype to treat breast cancer under MRI control without surgery was developed by the TRAIL group, a Bordeaux company and the University of Utah. A world first is currently in progress at Institut Bergonié. Similarly, FUS is now being tested on the heart to treat arrhythmias in collaboration with the IHU Lyric. Translational research also involves improving existing techniques for understanding pathophysiology. TRAIL physicists and neuroimaging specialists have just done this by improving the anatomical resolution of MRI to find the vulnerable area of the brain in memory disorders of patients with inflammatory diseases.

IHU Liryc

Objective: studying, diagnosing and treating electrophysiological disorders of the heart, which are the cause of numerous cardiovascular diseases and sudden deaths, and are consequently directly or indirectly responsible for nearly one third of deaths worldwide.

Under the leadership of Michel Haïssaguerre.

LIRYC – L’Institut de RYthmologie et modélisation Cardiaque – is a  University-Hospital Institute (IHU) dedicated to research, care, innovation and teaching to increase understanding of electrophysiological disorders of the heart, for the benefit of patients.

Founded in 2011 under the leadership of Professor Michel Haïssaguerre, it is jointly managed by the University and the Bordeaux University Hospital (CHU), and housed in the Bordeaux University foundation, which thus directly contributes to its structuring.

On the global scale, 90% of heart research is focused on the study of the cardiac pump and its blood vessels; very few research centers specifically focus on cardiac electricity. LYRIC is convinced that the study of this electrical harmony is fundamental to make headway in the field of cardiovascular disorders and thus reduce related mortality.

Given the aging of the population, the medical and economic implications of electrophysiological disorders of the heart are enormous. To come to grips with these complex disorders, a multi-disciplinary approach is required. By bringing together national and international experts from all disciplines, Liryc wishes to address this challenge.



Sophie Vialle
Communication manager
Tel : 05 35 38 18 88

150 researchers of 15 different nationalities 20 practitioners  over 200 scientific publications per year
1st contributor of communications to the Heart Rhythm Society meeting (Denver, USA) 1st annual international event in electrophysiology and heart stimulation  
Pr. Michel Haïssaguerre, Directeur de l'IHU Liryc© European Society of Cardiology

Out of the 50,000 sudden deaths per year, 20% apparently have a normal electrocardiogram, and a normal myocardial structure is seen in ultrasound and MRI scans. It's with such cases that we have to go a lot further and identify all possible eletrophysiological problems. We must manage to determine the risks much more precisely, so that individuals are not exposed to premature death.

Pr. Michel Haïssaguerre,
Director of the Liryc IHU

Zoom ...
L’année 2016 marquée par l’inauguration de l’IHU LirycL’année 2016 marquée par l’inauguration de l’IHU Liryc

Le 4 novembre 2016, autour du directeur Michel Haïssaguerre, l’ensemble des responsables institutionnels locaux ont inauguré officiellement ce chef d’œuvre scientifique. Devant près de 300 personnes, patients et industriels ont témoigné de leur prise en charge et collaboration avec l’institut. Cet IHU démultiplie le potentiel de recherche clinique en cardiologie et créé une dialectique commune entre tous les acteurs de ce domaine. Depuis la genèse du projet en 2011, l’IHU Lyric a fait le pari de la spécialisation. La recherche cardiaque mondiale est, à 90%, concentrée sur l’étude de la pompe cardiaque et ses vaisseaux. Dans ce contexte, les chercheurs de Bordeaux se concentrent sur l’électricité cardiaque, convaincus que l’étude de cette harmonie électrique est fondamentale pour avancer dans le domaine des...